the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Telegram boss Durov brought in front of French judge for questioning

PARIS: Telegram founder Pavel Durov was brought in front of an investigative judge for questioning following his arrest in France last weekend, German Press Agency (dpa) learned from Paris prosecutors on Wednesday.

Formal proceedings, which could ultimately lead to a criminal trial if investigators believe there is sufficient evidence, could be launched against Durov following the judge’s interrogation.

Police custody for Durov, who is wanted in France and was detained after arriving at Paris’ Le Bourget airport on Saturday upon arrival from Azerbaijan, was reportedly extended on Sunday evening.

His arrest came amid a preliminary inquest into Telegram’s lack of moderation and cooperation with law enforcement regarding drug trafficking, fraud and child-abuse offences on the social media platform, according to local media.

In a statement released following Durov’s arrest, Telegram said the online messaging service was complying with EU laws and had not violated any regulations.

According to prosecutors, French authorities launched preliminary investigations into Durov some time ago, under suspicion that he was complicit in drug trafficking, fraud and several offences relating to child abuse due to a lack of intervention at Telegram and insufficient cooperation with the authorities.

It was initially unclear why Durov, who was born in Russia and holds French citizenship, had travelled to Paris while being wanted in France. Telegram, a popular messaging app, has long faced accusations of not taking a strong enough stance against hate speech and other illegal activities.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings